Abnormal glomerular and tubular function during angiotensin converting enzyme inhibition in renovascular hypertension evaluated by the lithium clearance method

European Journal of Clinical Investigation
E B PedersenH K Nielsen

Abstract

Glomerular filtration rate (GFR) and tubular function were measured by means of the lithium clearance technique in 14 patients with renovascular hypertension (RVH) and eight patients with essential hypertension (EH) before and after oral administration of captopril 25 mg. In RVH captopril reduced 51-Cr-EDTA clearance (67.3 (median) to 47.5 ml min-1, P less than 0.01), proximal absolute reabsorption of fluid (53.9 to 41.5 ml min-1, P less than 0.01) and distal absolute reabsorption of sodium (2195 to 1402 mumol min-1, P less than 0.01), whereas proximal fractional reabsorption increased slightly (77.5 to 80.2%, P less than 0.02). In EH, however, these parameters were practically unaffected by captopril. In both RVH and EH plasma concentrations of angiotensin II and aldosterone were reduced after captopril, but atrial natriuretic peptide in plasma and urinary excretion rate of prostaglandin E2 were unchanged. Blood pressure decreased after captopril in both groups, but the maximum fall in systolic BP was more pronounced in RVH (22%) than EH (13%). It is concluded that angiotensin converting enzyme inhibition markedly reduced absolute reabsorption in both the proximal and distal tubules in RVH, in contrast to EH, predominantly due...Continue Reading

References

Jul 1, 1978·Prostaglandins and Medicine·S Y TanP J Mulrow
Mar 15, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·A M KappelgaardJ Giese
Apr 1, 1976·The American Journal of Physiology·C BaylisB M Brenner
Sep 16, 1985·Klinische Wochenschrift·H Sonnenberg
Dec 1, 1987·International Journal of Cardiology·A R ThomassenE B Pedersen
May 1, 1986·Circulation Research·B J Ballermann, B M Brenner
Apr 1, 1986·Clinical and Experimental Pharmacology & Physiology·J ZhuoS L Skinner
Feb 1, 1981·Circulation Research·N R LevensR M Carey
Feb 17, 1983·The New England Journal of Medicine·W B Blythe
Jun 1, 1981·Kidney International·J P Kokko

❮ Previous
Next ❯

Citations

May 1, 1991·Hypertension·M Martinez-Maldonado
Sep 22, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Rune V OvergaardHenrik Madsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.